---
schema_version: "secwatch.filing_event.v1"
accession: "0001125345-23-000081"
form_type: "8-K"
ticker: "MGNX"
cik: "0001125345"
company_name: "MACROGENICS INC"
filed_at: "2023-06-02T23:59:59+00:00"
generated_at: "2026-06-14T07:58:26.980933+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# MacroGenics stockholders elect directors, approve 2023 equity plan at annual meeting

## Summary
- Three Class I directors elected: Koenig, O'Brien, Siegel; each with over 41M votes for.
- Ernst & Young ratified as independent auditor for FY 2023 with 47.6M for vs 5.0M against.
- Advisory vote on named executive officer compensation approved with 43.6M for (non-binding).
- 2023 Equity Incentive Plan approved with 32.3M for, 16.8M against; broker non-votes 3.6M.

## SEC filing metadata
- accession: 0001125345-23-000081
- form_type: 8-K
- ticker: MGNX
- cik: 0001125345
- company_name: MACROGENICS INC
- filed_at: 2023-06-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1125345/000112534523000081/0001125345-23-000081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1125345/000112534523000081/mgnx-20230531.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001125345-23-000081
- JSON: https://secwatch.observer/filing/0001125345-23-000081.json
- Plain text: https://secwatch.observer/filing/0001125345-23-000081.txt

## Key facts
- Shareholder Votes
  MACROGENICS INC shareholders approved Approval of the MacroGenics, Inc. 2023 Equity Incentive Plan. at the 2023-05-31 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-05-31
  source text: Proposal 4 . To approve the MacroGenics, Inc. 2023 Equity Incentive Plan (the "2023 Plan"). Stockholders approved the 2023 Plan. The voting results were as follows: For Against Abstain Broker Non-Votes 32,287,594 16,781,647 5,964 3,614,159
  evidence_url: https://www.sec.gov/Archives/edgar/data/1125345/000112534523000081/0001125345-23-000081-index.htm
- Shareholder Votes
  MACROGENICS INC shareholders approved Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2023. at the 2023-05-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-31
  source text: Proposal 2 . The ratification of the appointment by the Audit Committee of the Board of Directors of the Company of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2023. Proposal 2 was approved. The voting results were as follows: For Against Abstain Broker Non-Votes 47,636,172 5,024,405 28,787 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1125345/000112534523000081/0001125345-23-000081-index.htm
- Shareholder Votes
  MACROGENICS INC shareholders approved Advisory vote to approve the compensation of the Company's named executive officers. at the 2023-05-31 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-05-31
  source text: Proposal 3 . To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. Stockholders approved the compensation of the Company's named executive officers. The voting results were as follows: For Against Abstain Broker Non-Votes 43,633,412 5,433,960 7,833 3,614,159
  evidence_url: https://www.sec.gov/Archives/edgar/data/1125345/000112534523000081/0001125345-23-000081-index.htm
- Shareholder Votes
  MACROGENICS INC shareholders approved Election of three nominees to serve as Class I directors, each for a term of three years. at the 2023-05-31 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-05-31
  source text: Proposal 1 . The election of three nominees to serve as Class I directors, each for a term of three years. All director nominees were elected. The voting results were as follows: Nominees For Withheld Broker Non-Votes Scott Koenig, M.D., Ph.D. 43,810,609 5,264,596 3,614,159 Federica O'Brien 43,467,303 5,607,902 3,614,159 Jay Siegel, M.D. 41,788,095 7,287,110 3,614,159
  evidence_url: https://www.sec.gov/Archives/edgar/data/1125345/000112534523000081/0001125345-23-000081-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.